Ginseng - Drug Monograph

Comprehensive information about Ginseng including mechanism, indications, dosing, and safety information.

Introduction

Ginseng refers to several species of the genus Panax (true ginseng) and other plants that are sometimes referred to as ginseng. The most commonly used and studied varieties are Panax ginseng (Asian/Korean ginseng) and Panax quinquefolius (American ginseng). Ginseng has been used for centuries in traditional medicine systems, particularly in East Asia, and is classified as an adaptogen—a substance that purportedly helps the body adapt to stress and exerts a normalizing effect on physiological processes.

Mechanism of Action

The pharmacological activity of ginseng is attributed to its active compounds, primarily ginsenosides (also called panaxosides), which are steroid-like saponins. These compounds demonstrate multiple mechanisms including:

  • Modulation of the hypothalamic-pituitary-adrenal axis
  • Antioxidant properties through free radical scavenging
  • Anti-inflammatory effects via inhibition of NF-κB and COX-2 pathways
  • Enhancement of nitric oxide production leading to vasodilation
  • Modulation of neurotransmitter systems (particularly GABA and glutamate)
  • Improvement of insulin sensitivity and glucose metabolism
  • Potential immunomodulatory effects through cytokine regulation

Indications

Note: Ginseng is regulated as a dietary supplement, not an FDA-approved medication

Common traditional and evidence-supported uses include:

  • Physical and mental fatigue
  • Cognitive enhancement and memory support
  • Immune system support
  • Diabetes mellitus adjunct therapy (modest glucose-lowering effects)
  • Erectile dysfunction
  • Quality of life improvement during cancer treatment
  • Stress adaptation support

Dosage and Administration

Standardized preparations typically contain 2-3% total ginsenosides.

Common dosing:
  • Dried root: 0.5-2 g daily
  • Standardized extract: 100-400 mg daily
  • Tincture (1:5): 5-10 mL daily
Administration:
  • Typically administered orally
  • Often taken in divided doses with meals
  • Cyclical administration (3-4 weeks on, 1-2 weeks off) is commonly recommended to prevent potential tolerance
Special populations:
  • Elderly: Start with lower doses
  • Hepatic/renal impairment: No specific guidelines; use caution
  • Pregnancy/lactation: Not recommended due to insufficient safety data

Pharmacokinetics

Absorption: Ginsenosides are poorly absorbed due to their large molecular structure and low lipid solubility. Bioavailability is enhanced when taken with food. Distribution: Distributed throughout body tissues; some ginsenosides cross the blood-brain barrier. Metabolism: Extensive first-pass metabolism via gut microbiota and hepatic cytochrome P450 enzymes (particularly CYP3A4). Elimination: Primarily excreted via bile and feces; renal elimination is minimal. Elimination half-life varies by specific ginsenoside compound.

Contraindications

  • Known hypersensitivity to ginseng or plants in the Araliaceae family
  • Pregnancy and breastfeeding (due to insufficient safety data)
  • Uncontrolled hypertension
  • Acute illness with fever
  • Mania or bipolar disorder (may exacerbate symptoms)
  • Hormone-sensitive conditions (breast cancer, endometriosis, uterine fibroids)

Warnings and Precautions

  • May cause insomnia, especially if taken later in the day
  • Use caution in patients with cardiovascular disease due to potential effects on blood pressure and heart rate
  • May affect blood glucose levels—monitor closely in diabetics
  • Potential for bleeding risk—use caution in patients with bleeding disorders or taking anticoagulants
  • May interact with immunosuppressants in transplant patients
  • Quality control issues: Products may vary significantly in ginsenoside content and may be adulterated

Drug Interactions

Major interactions:
  • Warfarin: May decrease INR (increased risk of thrombosis)
  • MAO inhibitors: Risk of headache, tremors, and manic episodes
  • Immunosuppressants: May decrease efficacy
Moderate interactions:
  • Antidiabetic medications: Enhanced hypoglycemic effects
  • Antihypertensives: Potential interference with blood pressure control
  • Stimulants: Additive CNS stimulation
  • Alcohol: May increase alcohol clearance
Cytochrome P450 interactions:
  • May inhibit CYP3A4, CYP2D6, and CYP2C9
  • Potential interactions with substrates of these enzymes

Adverse Effects

Common (≥1%):
  • Insomnia
  • Headache
  • Gastrointestinal discomfort
  • Agitation/nervousness
Less common:
  • Hypertension or hypotension
  • Tachycardia
  • Allergic reactions
  • Breast tenderness
  • Vaginal bleeding
  • Hypoglycemia
Rare but serious:
  • Stevens-Johnson syndrome (case reports)
  • Manic episodes in susceptible individuals
  • Severe allergic reactions

Monitoring Parameters

  • Blood pressure (baseline and periodically)
  • Blood glucose levels in diabetics
  • INR in patients taking warfarin
  • Mood and sleep patterns
  • Signs of allergic reactions
  • Medication efficacy for intended use

Patient Education

  • Ginseng is a supplement, not an FDA-approved medication
  • Choose products from reputable manufacturers that standardize ginsenoside content
  • Inform all healthcare providers about ginseng use
  • Be aware of potential interactions with prescription medications
  • Monitor for changes in sleep patterns, mood, or energy levels
  • Report any unusual bleeding, allergic reactions, or persistent side effects
  • Consider cyclical use (3-4 weeks on, 1-2 weeks off) to maintain effectiveness
  • Discontinue use at least 2 weeks before scheduled surgery

References

1. Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res. 2017;41(4):435-443.

2. Lee NH, Yoo SR, Kim HG, Cho JH, Son CG. Safety and tolerability of Panax ginseng root extract: a randomized, placebo-controlled, clinical trial. PLoS One. 2015;10(4):e0123472.

3. Shergis JL, Zhang AL, Zhou W, Xue CC. Panax ginseng in randomised controlled trials: a systematic review. Phytother Res. 2013;27(7):949-965.

4. Natural Medicines Comprehensive Database. Ginseng Professional Monograph. Therapeutic Research Center. 2023.

5. World Health Organization. WHO Monographs on Selected Medicinal Plants - Volume 1. Geneva: World Health Organization; 1999.

6. Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry. 2011;72(8):689-699.

7. Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician. 2003;68(8):1539-1542.

8. European Medicines Agency. Assessment report on Panax ginseng C.A. Meyer, radix. EMA/HMPC/321232/2012. 2014.

Note: This information is for educational purposes only and should not replace professional medical advice. Patients should consult with healthcare providers before starting any new supplement regimen.

Medical Disclaimer

The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The content on MedQuizzify is designed to support, not replace, the relationship that exists between a patient and their healthcare provider. If you have a medical emergency, please call your doctor or emergency services immediately.

How to Cite This Article

admin. Ginseng - Drug Monograph. MedQuizzify [Internet]. 2025 Sep 08 [cited 2025 Sep 09]. Available from: http://medquizzify.pharmacologymentor.com/blog/drug-monograph-ginseng

Enjoyed this post?

Subscribe to our newsletter and get more educational insights, quiz tips, and learning strategies delivered weekly to your inbox.